These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 10747680)

  • 1. Determining the differences among cost savings, cost avoidance, and cost reduction.
    Howard KB; Pathak DS
    Pharm Pract Manag Q; 1999 Oct; 19(3):1-7. PubMed ID: 10747680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic evaluations of clinical pharmacy services--1988-1995. The Publications Committee of the American College of Clinical Pharmacy.
    Schumock GT; Meek PD; Ploetz PA; Vermeulen LC
    Pharmacotherapy; 1996; 16(6):1188-208. PubMed ID: 8947994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACCP: economic evaluations of clinical pharmacy services: 2001-2005.
    Perez A; Doloresco F; Hoffman JM; Meek PD; Touchette DR; Vermeulen LC; Schumock GT;
    Pharmacotherapy; 2009 Jan; 29(1):128. PubMed ID: 19113803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost benefit and cost effectiveness analysis: a bibliography for pharmacists.
    Lunik MC; Segal R
    Hosp Pharm; 1986 Nov; 21(11):1072-5. PubMed ID: 10311748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purchasing premixed products.
    Geberbauer CW
    J Healthc Mater Manage; 1988; 6(2):40, 42, 44-5. PubMed ID: 10286278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electronic prescribing: a review of costs and benefits.
    Corley ST
    Top Health Inf Manage; 2003; 24(1):29-38. PubMed ID: 12674393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of gentamicin premixed admixtures: cost and clinical utility.
    Zarowitz BJ; Owen H; Popovich J; Pancorbo S
    Hosp Pharm; 1987 Mar; 22(3):257-60. PubMed ID: 10311980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving care and reducing costs in the ICU.
    Ivey MF
    Am J Hosp Pharm; 1994 Dec; 51(24):3029. PubMed ID: 7856621
    [No Abstract]   [Full Text] [Related]  

  • 9. Proposed drug-drug cost effectiveness methodology.
    Gagnon JP; Osterhaus JT
    Drug Intell Clin Pharm; 1987 Feb; 21(2):211-6. PubMed ID: 3103997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The high cost of customization: compounding drugs.
    Cohen MR
    Hosp Pharm; 1991 Apr; 26(4):384-5. PubMed ID: 10113578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-benefit analysis of clinical pharmacy services in a community hospital.
    Meisel S
    Hosp Pharm; 1985 Dec; 20(12):904-6. PubMed ID: 10311347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inventory management to reduce costs: a case study.
    Wilson S
    Hosp Pharm; 1995 Sep; 30(9):759-61, 765-6. PubMed ID: 10151280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Clinical pharmacists save hospitals money'.
    Wagner M
    Mod Healthc; 1992 Dec 21-28; 22(51):17. PubMed ID: 10122783
    [No Abstract]   [Full Text] [Related]  

  • 15. Projected cost savings associated with cefmetazole: a new cephamycin for the hospitalized patient.
    Crane VS
    Hosp Formul; 1991 Apr; 26(4):302-6, 309-10. PubMed ID: 10109799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost-effectiveness of clinical pharmacist intervention on tobramycin prescribing.
    Khanderia U
    Hosp Formul; 1986 Oct; 21(10):1049-50, 1055-6. PubMed ID: 10311722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacy analyzes costs, savings of computer information system.
    Neal T
    Hospitals; 1981 Feb; 55(3):70-4. PubMed ID: 6778809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation and pharmacoeconomic analysis of a clinical staff pharmacist practice model.
    Nesbit TW; Shermock KM; Bobek MB; Capozzi DL; Flores PA; Leonard MC; Long JK; Militello MA; White DA; Barone LD; Goldman MP; Kvancz DA
    Am J Health Syst Pharm; 2001 May; 58(9):784-90. PubMed ID: 11351918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Financial modeling of extramural programs: do they generate net savings?
    Dodge WW; Hardigan J; Comer RW
    J Dent Educ; 1999 Dec; 63(12):890-5. PubMed ID: 10650414
    [No Abstract]   [Full Text] [Related]  

  • 20. Economic impact of a pharmacy resident in an assisted living facility-based medication therapy management program.
    Maack B; Miller DR; Johnson T; Dewey M
    Ann Pharmacother; 2008 Nov; 42(11):1613-20. PubMed ID: 18940921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.